Tufts professors receive $8 million investment for biotech startup

Morphoceuticals, a biotech company co-founded by Tufts professors Michael Levin and David Kaplan, recently received $8 million in seed funding from Prime Movers Lab and Juvenescence. The company is taking a new approach to the challenge of regenerative medicine by exploring the bioelectric controls of the human body to induce the regeneration of tissue, limbs […]


COPYRIGHT 2023 THE TUFTS DAILY. ALL RIGHTS RESERVED.